Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss linked to prostate enlargement; stress and family history important factors.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The method can effectively extract biomedical information without needing expert annotation, performing better than previous models.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

High androgen levels in young women with PCOS are linked to higher blood pressure.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

SHBG may be a useful early indicator and treatment target for PCOS.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

FOXN1 gene variants cause low T cells and immune issues from birth.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Eating glucoraphanin can help prevent psychosis in offspring whose mothers had immune system activation.